Table 5.
Characteristics of studies Group 2 (BOP + probing depth ≥ 6 mm + bone loss ≥ 2 mm)
| Studies | Characteristics | Results | ||||||
|---|---|---|---|---|---|---|---|---|
| Population | Sample (N)(P) | Sample (N)(DI) | Design follow-up | Time load (Y) | Diagnostic | Rate (P) (%) | Rate (DI) (%) | |
| Lee [47] | Australia | 60 | 117 | Case–control | 8 (5–13.46) | BOP + PD ≥ 5 mm + BL > 2 mm | 26.6666 | 19.6581 |
| Marrone [49] | EU | 103 | 266 | Cross-sectional | > 5 | BOP/suppuration + PD > 5 mm + BL > 2 mm | 36.8932 | 22.9323 |
| Meijer [50] | EU | 140 | 276 | Cohort | 5 | BOP/suppuration + BL ≥ 2 mm | 17.1428 | 11.5942 |
| Nobre [53] | EU | 353 | 1238 | Cohort | 5 | BOP/suppuration + PD ≥ 5 mm + BL ≥ 2 mm | 24.0793 | Missing |
| Papaspyridakos (2019) | USA | 41 | 359 | Cohort | 5 | BOP/suppuration + BL > 2 mm | Missing | 8.0779 |
| Pimentel [56] | SA | 147 | 490 | Cross-sectional | > 5 | BOP/suppuration + PD > 4 mm + BL > 2 mm | 19.0476 | 9.1837 |
| Ravald [57] | EU | 46 | 371 | Longitudinal | 12 to 15 | BOP/suppuration + PD ≥ 4 mm + BL ≥ 2 mm | 21.7391 | 3.7786 |
| Ravidá [58] | USA | 145 | 382 | Longitudinal | 5.2–6.5 | BOP + BL > 2 mm | 16.5517 | 9.9476 |
| Rodrigo [66] | EU | 275 | 474 | Cohort | 9 ± 1.7 | BOP + BL ≥ 2 mm | 24 | 19.6202 |